(Q37808135)

23 August 2017

title

Stem cells and their derivatives: a renaissance in cardiovascular translational research (English)

1 reference

23 August 2017

1 reference

Steven J Kattman

1

1 reference

23 August 2017

Chad H Koonce

series ordinal

2

1 reference

23 August 2017

Bradley J Swanson

series ordinal

3

1 reference

23 August 2017

Blake D Anson

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Journal of Cardiovascular Translational Research

23 August 2017

published in

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

66-72

1 reference

Embryonic stem cell lines derived from human blastocysts

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Functional cardiomyocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cardiomyocyte differentiation of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cardiac applications for human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Expression of a single transfected cDNA converts fibroblasts to myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Pluripotent stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Reprogramming of T cells from human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Reprogramming of human peripheral blood cells to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Coexpression of platelet-derived growth factor receptor alpha and fetal liver kinase 1 enhances cardiogenic potential in embryonic stem cell differentiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

N-cadherin is a useful marker for the progenitor of cardiomyocytes differentiated from mouse ES cells in serum-free condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Transgenic enrichment of cardiomyocytes from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Identification and selection of cardiomyocytes during human embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Drug-induced long QT and torsade de pointes: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Alfuzosin delays cardiac repolarization by a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Excitation-contraction coupling and mitochondrial energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

The significance of mitochondrial toxicity testing in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Model systems for the discovery and development of antiarrhythmic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-010-9235-1

Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy

21 January 2018

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity

1 reference

12 December 2020

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

1 reference

12 December 2020

Drug-induced hERG block and long QT syndrome

1 reference

12 December 2020

Epigenetic memory in induced pluripotent stem cells

1 reference

12 December 2020

A fresh look at iPS cells

1 reference

12 December 2020

10.1007/S12265-010-9235-1

Identifiers

DOI

1 reference

23 August 2017

1 reference